Natural killer cells in ovarian cancer therapy: mechanisms, evasion, and therapeutic innovations
- DOI
- 10.1007/s10787-026-02397-x
- Published
- 2026-09-17
- Container
- Inflammopharmacology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s10787-026-02397-x,
title = {Natural killer cells in ovarian cancer therapy: mechanisms, evasion, and therapeutic innovations},
author = {Weihong Long and Caiyun Zhang and Can Zhang and Junjie Ni and Chao Xiong and Xu Wu and Mingxing Li and Fukuan Du and Yu Chen and Yueshui Zhao and Jing Shen and Chi Hin Cho and Zhangang Xiao},
year = {2026},
journal = {Inflammopharmacology},
doi = {10.1007/s10787-026-02397-x},
url = {https://doi.org/10.1007/s10787-026-02397-x}
}RIS
TY - JOUR TI - Natural killer cells in ovarian cancer therapy: mechanisms, evasion, and therapeutic innovations AU - Weihong Long AU - Caiyun Zhang AU - Can Zhang AU - Junjie Ni AU - Chao Xiong AU - Xu Wu AU - Mingxing Li AU - Fukuan Du AU - Yu Chen AU - Yueshui Zhao AU - Jing Shen AU - Chi Hin Cho AU - Zhangang Xiao PY - 2026 JO - Inflammopharmacology DO - 10.1007/s10787-026-02397-x UR - https://doi.org/10.1007/s10787-026-02397-x ER -
APA
Long, W., Zhang, C., Zhang, C., Ni, J., Xiong, C., Wu, X., Li, M., Du, F., Chen, Y., Zhao, Y., Shen, J., Cho, C. H., & Xiao, Z. (2026). Natural killer cells in ovarian cancer therapy: mechanisms, evasion, and therapeutic innovations. Inflammopharmacology. https://doi.org/10.1007/s10787-026-02397-x
Source records
- crossref · retrieved 2026-09-25T13:51:30.670Z